Literature DB >> 10698542

Simultaneous analysis of dextran-methylprednisolone succinate, methylprednisolone succinate, and methylprednisolone by size-exclusion chromatography.

R Mehvar1.   

Abstract

An analytical HPLC method is reported for simultaneous measurement of low (1.0-100 microg ml(-1)) concentrations of dextran-methylprednisolone succinate (DEX-MPS) and its degradation products methylprednisolone hemisuccinate (MPS) and methylprednisolone (MP). The analytes were detected at 250 nm after resolution using a size exclusion column with a mobile phase of KH2PO4 (10 mM): acetonitrile (3:1) and a flow rate of 1 ml min(-1). The resolution of MP and MPS peaks was substantially affected by the pH of the mobile phase; while MP and MPS co-eluted at pH 3.4, they were baseline-resolved at pH > or = 5. Linear relationships (r > or = 0.997) were found between the detector response and the concentrations of the analytes (1.0-100 microg ml(-1) for MP and MPS and 2.5-100 microg ml(-1) for DEX-MPS). Intra- and inter-run error (< 13%) and precision (CV of < or = 6%) data indicated that the assay could accurately and precisely quantitate all three components in the examined concentration range. The application of the assay to determination of degree of substitution, purity, and stability of DEX-MPS was also demonstrated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10698542     DOI: 10.1016/s0731-7085(98)00308-2

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  8 in total

1.  Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: immunosuppressive effects after in vivo administration to rats.

Authors:  R Mehvar; D A Hoganson
Journal:  Pharm Res       Date:  2000-11       Impact factor: 4.200

2.  Attenuation of acute rejection in a rat liver transplantation model by a liver-targeted dextran prodrug of methylprednisolone.

Authors:  Anjaneya P Chimalakonda; Donald L Montgomery; Jon A Weidanz; Imam H Shaik; Justin H Nguyen; John J Lemasters; Eiji Kobayashi; Reza Mehvar
Journal:  Transplantation       Date:  2006-03-15       Impact factor: 4.939

3.  Attenuation of Kupffer cell activation in cold-preserved livers after pretreatment of rats with methylprednisolone or its macromolecular prodrug.

Authors:  Anjaneya P Chimalakonda; Reza Mehvar
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

4.  Effects of methylprednisolone and its liver-targeted dextran prodrug on ischemia-reperfusion injury in a rat liver transplantation model.

Authors:  Anjaneya P Chimalakonda; Reza Mehvar
Journal:  Pharm Res       Date:  2007-10-06       Impact factor: 4.200

5.  Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: local immunosuppressive effects in liver after systemic administration to rats.

Authors:  Anjaneya P Chimalakonda; Reza Mehvar
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

6.  Effects of duration of ischemia and donor pretreatment with methylprednisolone or its macromolecular prodrug on the disposition of indocyanine green in cold-preserved rat livers.

Authors:  Anjaneya P Chimalakonda; Reza Mehvar
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

7.  Development and validation of a rapid HPLC method for simultaneous analysis of budesonide and its novel synthesized hemiesters in colon specific formulations.

Authors:  J Varshosaz; J Emami; N Tavakoli; M Minaiyan; N Rahmani; F Ahmadi; F Dorkoosh
Journal:  Res Pharm Sci       Date:  2011-07

8.  Synthesis of budesonide conjugates and their anti-inflammatory effects: a preliminary study.

Authors:  Yan Yan; Pengchong Wang; Ruiying Li; Ying Sun; Rui Zhang; Chuanchuan Huo; Jianfeng Xing; Yalin Dong
Journal:  Drug Des Devel Ther       Date:  2019-02-19       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.